Price target upside
Bristol-Myers Squibb Company Price Target: +3.7% vs Current Price
BMY target gap is +3.7% from $63.83 to $66.21. As of 2026-08-16.
Direct answer
Bristol-Myers Squibb Company's analyst target implies +3.7%.
The average target is $66.21 compared with a recorded current price of $63.83.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 16, 2026.
Get free Bristol-Myers Squibb Company email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $63.83
- Average price target
- $66.21
- High price target
- $80.00
- Low price target
- $40.00
- Low target gap
- -37.3%
- Target upside
- +3.7%
- High target gap
- +25.3%
- Target range width
- 62.7%
- Consensus rating
- Buy
- Analysts
- 24
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026